The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 14, 2022

Filed:

Nov. 13, 2017
Applicant:

Cerebrotech Medical Systems, Inc., Pleasanton, CA (US);

Inventors:

Moshe Oziel, Jerusalem, IL;

Boris Rubinsky, El Cerrito, CA (US);

Mitchell Elliott Levinson, Pleasanton, CA (US);

Eugene Mark Shusterman, Pleasanton, CA (US);

Assignee:

Cerebrotech Medical Systems, Inc., Pleasanton, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); A61B 5/05 (2021.01); A61B 5/053 (2021.01); A61B 5/03 (2006.01); A61B 5/0522 (2021.01); G16H 40/63 (2018.01); G16H 50/30 (2018.01); G16H 50/20 (2018.01); A61B 5/245 (2021.01); A61B 7/00 (2006.01); A61B 8/08 (2006.01);
U.S. Cl.
CPC ...
A61B 5/0522 (2013.01); A61B 5/0022 (2013.01); A61B 5/0037 (2013.01); A61B 5/0042 (2013.01); A61B 5/031 (2013.01); A61B 5/05 (2013.01); A61B 5/245 (2021.01); A61B 5/4064 (2013.01); A61B 5/4839 (2013.01); A61B 5/4848 (2013.01); A61B 5/4875 (2013.01); A61B 5/4878 (2013.01); A61B 5/6803 (2013.01); A61B 5/6814 (2013.01); A61B 5/6831 (2013.01); A61B 5/721 (2013.01); A61B 5/7214 (2013.01); A61B 5/7225 (2013.01); A61B 5/7246 (2013.01); A61B 5/7257 (2013.01); A61B 5/7275 (2013.01); A61B 5/7278 (2013.01); A61B 5/7282 (2013.01); G16H 40/63 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); A61B 7/00 (2013.01); A61B 8/0808 (2013.01); A61B 8/5261 (2013.01); A61B 2560/0223 (2013.01); A61B 2562/0223 (2013.01); A61B 2562/166 (2013.01); A61B 2562/182 (2013.01); A61B 2562/222 (2013.01); A61B 2576/026 (2013.01);
Abstract

A method for measuring an intracranial bioimpedance in a patient's head, to help evaluate cerebral autoregulation, may involve securing a volumetric integral phase-shift spectroscopy (VIPS) device to the patient's head, measuring the intracranial bioimpedance with the VIPS device by measuring a phase shift between a magnetic field transmitted from a transmitter on one side of a VIPS device and a magnetic field received at a receiver on another side of the VIPS device, at one or more frequencies, and evaluating cerebral autoregulation in the intracranial bioimpedance, using a processor in the VIPS device.


Find Patent Forward Citations

Loading…